ID: ALA1939727

Max Phase: Preclinical

Molecular Formula: C35H56I2N14O8

Molecular Weight: 800.92

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[N+](C)(CCCC(=O)NCCCNC(=O)CCC[N+](C)(C)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O.[I-].[I-]

Standard InChI:  InChI=1S/C35H54N14O8.2HI/c1-48(2,14-20-26(52)28(54)34(56-20)46-18-44-24-30(36)40-16-42-32(24)46)12-5-8-22(50)38-10-7-11-39-23(51)9-6-13-49(3,4)15-21-27(53)29(55)35(57-21)47-19-45-25-31(37)41-17-43-33(25)47;;/h16-21,26-29,34-35,52-55H,5-15H2,1-4H3,(H4-2,36,37,38,39,40,41,42,43,50,51);2*1H/t20-,21-,26-,27-,28-,29-,34-,35-;;/m1../s1

Standard InChI Key:  IVSFOCIXXIYRKQ-CLYRIGIUSA-N

Associated Targets(non-human)

metJ Met repressor (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 800.92Molecular Weight (Monoisotopic): 800.4395AlogP: -2.60#Rotatable Bonds: 18
Polar Surface Area: 296.82Molecular Species: NEUTRALHBA: 18HBD: 8
#RO5 Violations: 3HBA (Lipinski): 22HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.11CX Basic pKa: 5.22CX LogP: -12.36CX LogD: -12.36
Aromatic Rings: 4Heavy Atoms: 57QED Weighted: 0.04Np Likeness Score: 0.26

References

1. Joce C, White R, Stockley PG, Warriner S, Turnbull WB, Nelson A..  (2012)  Design, synthesis and in vitro evaluation of novel bivalent S-adenosylmethionine analogues.,  22  (1): [PMID:22137339] [10.1016/j.bmcl.2011.11.017]

Source